Close

Aegerion Pharma (AEGR) Receives Approval in Japan for JUXTAPID Pricing

November 17, 2016 4:16 PM EST Send to a Friend
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) announced that Japan’s Ministry of Health, Labor & Welfare (MHLW) has approved pricing of JUXTAPID ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login